MED vs HRB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

MED

46.5
AI Score
VS
HRB Wins

HRB

47.8
AI Score

Investment Advisor Scores

MED

47score
Recommendation
HOLD

HRB

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MED HRB Winner
Revenue 76.04M 2.80B HRB
Net Income -2.12M 439.92M HRB
Net Margin -2.8% 15.7% HRB
ROE -1.1% -1805.0% MED
ROA -0.8% 13.0% HRB
Total Assets 252.05M 3.39B HRB
Cash 71.53M 867.01M HRB
Current Ratio 4.80 1.00 MED
Free Cash Flow -836,000 519.57M HRB

Relative Price Performance (Last 90 Days)

MED 1M: -11.1% · 3M: -10.7% HRB 1M: +12.9% · 3M: +44.6%

Current Technical Phase

MED

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.7%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $9.74

HRB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.5% over 20 days), RSI 64

RSI (14): 64.2 · Price: $45.19

Fundamentals Snapshot

Metric MED HRB
Market Cap
Forward P/E -16.5 7.7
Trailing P/E 7.9
Revenue (TTM)
Revenue Growth -0.3% 0.1%
Gross Margin 0.7% 0.4%
Operating Margin -0.1% 0.4%
EPS -1.82 5.59
Dividend Yield 0.04%

Frequently Asked Questions

Based on our detailed analysis, HRB is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.